Domino effect: Proposed China CBD ban leads US-based BOTA to 'shut down' APAC expansion plans By Amanda Lim 05-May-2021 - Last updated on 05-May-2021 at 01:52 GMT Facebook Twitter Linkedin Email to a friend The firm behind US-based CBD skin care brand BOTA, Balanced Health Botanicals, says it will no longer invest in the APAC after China announced its proposal to ban the use of cannabis and cannabis extracts in cosmetics. Top 10 most-read cosmetics stories of April China CBD crackdown: Ban on cannabis cosmetics will likely halt sales online as authorities push 'anti-drug' stance 'A marathon, not a sprint': Product innovation and aggressive marketing key for success post-COVID-19 – Unilever's Lifebuoy Artificial skin: Shiseido plans to launch highly anticipated ‘second skin’ tech into market this year 'Botanical powerhouse': Lotus Herbals launches new premium clean beauty brand with aims to cross $10m mark Burning issue: How the COVID-19 pandemic is putting pressure on sunscreen testing processes Pandemic skin: Bio-essence targets opportunities by solving COVID-related skin care problems Domino effect: Proposed China CBD ban leads US-based BOTA to 'shut down' APAC expansion plans Tourist trap: Shiseido aims to restore growth in Japan without overreliance on travellers The new 'normal': How Lifebuoy and Lux are embracing Unilever's Positive Beauty vision Purposeful beauty: asa Beauty marries sustainability and luxury with refillable make-up concept Prev 1 … 6 7 8 9 10 11 Next